The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2022

Filed:

Aug. 03, 2020
Applicant:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Inventors:

Richard D. DiMarchi, Carmel, IN (US);

Alexei Kharitonenkov, Zionsville, IN (US);

Pengyun Li, Bloomington, IN (US);

Archita S. Agrawal, Bloomington, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/66 (2017.01); C07K 14/50 (2006.01); A61K 47/65 (2017.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61K 38/03 (2006.01); A61K 38/17 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01);
U.S. Cl.
CPC ...
A61K 47/66 (2017.08); A61K 38/03 (2013.01); A61K 38/1796 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 47/65 (2017.08); A61P 3/04 (2018.01); A61P 3/10 (2018.01); C07K 14/50 (2013.01);
Abstract

Disclosed herein are modified C-terminal fragments of FGF21 optimized for binding to Klotho β or antagonizing FGF21 activity. FGF21 peptides modified to comprise modifications to the C-terminal amino acid sequence are disclosed that have enhanced activity at the FGF21 receptor. Additionally, conjugates formed between the optimized FGF21 peptide fragments and insulin like peptides or nuclear hormone receptor ligands are provided.


Find Patent Forward Citations

Loading…